Unmet need in diabetic nephropathy: failed drugs or trials?

Lancet Diabetes Endocrinol. 2016 Aug;4(8):638-640. doi: 10.1016/S2213-8587(16)30045-6. Epub 2016 May 6.

Authors

Dick de Zeeuw¹, Hiddo J L Heerspink²

Affiliations

¹ Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, Netherlands. Electronic address: d.de.zeeuw@umcg.nl.
² Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, Netherlands.

PMID: 27160545
DOI: 10.1016/S2213-8587(16)30045-6

No abstract available

Publication types

Review

MeSH terms

Angiotensin Receptor Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / therapeutic use*
Clinical Trials as Topic / methods*
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / mortality
Diabetic Nephropathies / drug therapy*
Diabetic Nephropathies / mortality
Drugs, Investigational / therapeutic use
Humans
Hypoglycemic Agents / therapeutic use*

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Drugs, Investigational
Hypoglycemic Agents